TCON (TRACON Pharmaceuticals, Inc.) Prakiraan volume dodolan

Logo korporat perusahaan TRACON Pharmaceuticals, Inc. (TCON)

TRACON Pharmaceuticals (TCON) seeks stable revenue through the optimization of clinical trials for oncology drugs. A chart of the company's projected sales volumes is available in the GURU.Markets system, where 0.01 shows the current value of the metric. However, reducing trial timelines via its own CRO faces a critical barrier: asset liquidation and a lack of grants following the failure of final studies.

Pendapatan mangsa ngarep perusahaan: TRACON Pharmaceuticals (TCON) kanggo 04.07.2022 - 04.08.2024

Rincian analitis perusahaan TRACON Pharmaceuticals

- indikator valuasi pasar bisnis:
Analisis fundamental perusahaan:TRACON Pharmaceuticals, Inc
Produk merek TRACON Pharmaceuticals Inc.

TRACON Pharmaceuticals revenues depend on royalties and upfront payments for the development of targeted cancer therapies. This indicator determines the probable revenue range by comparing current inflows with the mathematical expectation. Growth in this metric signals high business adaptability, although extreme values increase the risk of a correction. By analyzing the company's target sales level, an investor assesses profit potential. Exceeding the upper boundary of the distribution on this chart confirms aggressive growth in commercial potential.

Pesaing TRACON Pharmaceuticals (TCON)

Volume dodolan mangsa ngarep perusahaan TEM (Tempus AI)|Dodolan mangsa ngarep perusahaan Qiagen Group|Prakiraan pendapatan perusahaan Ionis Pharma IONS|RGEN - Volume dodolan mangsa ngarep perusahaan|RNA - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan CRSP (CRISPR Therapeutics AG)|Sema4 (WGS) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan RARE (Ultragenyx)|Volume dodolan mangsa ngarep perusahaan BEAM|Prakiraan volume dodolan Sarepta Corp|Prakiraan pendapatan perusahaan Twist Bioscience, Inc. (TWST)|Volume dodolan mangsa ngarep perusahaan 10x Genomics TXG|Prakiraan pendapatan perusahaan Intellia Therapeutics NTLA|Prakiraan volume pendapatan perusahaan STOK (Stoke Therapeutics, Inc.)|BLFS - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Wave Pharma|mazetx.com (MAZE) - Prakiraan pendapatan perusahaan|SION - Dodolan mangsa ngarep perusahaan|PRME (Prime Medicine Inc) - Prakiraan volume dodolan|Taysha Gene Therapies, Inc. - Pendapatan sing dikarepake perusahaan|Prakiraan volume dodolan QURE|MGTX: Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan REGENXBIO RGNX|SLDB: Prakiraan pendapatan perusahaan|OCGN: Volume dodolan mangsa ngarep perusahaan|PACB - Prakiraan volume dodolan|BNTC (Benitec Corp) - Volume dodolan mangsa ngarep perusahaan|Prakiraan dodolan perusahaan Design Corp DSGN|Prakiraan pendapatan perusahaan Rocket Pharmaceuticals|Prakiraan volume dodolan 4D Molecular Therapeutics, Inc.|Prakiraan pendapatan perusahaan Lexeo (LXEO)|KRRO (Korro Bio Inc.) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan EDIT (Editas Medicine, Inc.)|Prakiraan volume dodolan Silence Therapeutics Corp SLN|PRQR - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan Codexis Inc CDXS|SGMO: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan NAUT|Prakiraan pendapatan perusahaan metagenomi.co|Prakiraan volume dodolan Precision BioSciences Inc.|Prakiraan volume dodolan GBIO|Boundless Bio, Inc. - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan XCUR (Exicure, Inc.)|Dodolan mangsa ngarep perusahaan Imunon, Inc. (IMNN)|PHIO - Prakiraan pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan MBIO (mustangbio.com)|RNAZ: Prakiraan volume dodolan|Prakiraan pendapatan perusahaan BNGO|APDN (Applied DNA Corp) - Prakiraan volume dodolan|BLUE: Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan ImmunoPrecise (IPA)|OMGA - Volume dodolan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Singular Genomics OMIC|Pendapatan mangsa ngarep perusahaan RGLS|Syros Pharmaceuticals, Inc. - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan Telesis Bio Inc. TBIO|UBX: Prakiraan volume dodolan